1型糖尿病胰岛移植对血糖控制与反向调节的长期改善
在宾夕法尼亚大学临床与转化研究中心,10例病程约27年的1型糖尿病患者按CIT07方案接受肝内胰岛移植,并与10名非糖尿病对照者比较。移植后24个月内所有患者维持接近正常的血糖(HbA1c≤6.5%,血糖70-180 mg/dL时间≥95%),低血糖反向调节激素、内生葡萄糖生成和自主神经症状反应在6个月和18个月时改善或恢复正常。
要点
- 移植后24个月内所有患者维持接近正常血糖,其中1例恢复小剂量胰岛素治疗。
- 胰岛素诱导低血糖时,胰高血糖素分泌在6个月和18个月时未完全恢复。
- 肾上腺素在6个月时改善、18个月时恢复正常,内生葡萄糖生成和症状在移植后6个月和18个月时恢复正常。
核心结论
- 在存在难治性低血糖的1型糖尿病患者中,肝内胰岛移植可带来葡萄糖反向调节和低血糖症状识别的长期改善,这些生理效应可能有助于移植后血糖稳定。
研究设计与样本
- 纵向研究,纳入10例病程约27年的1型糖尿病患者,在移植前及移植后6个月和18个月于宾夕法尼亚大学临床与转化研究中心接受研究,并与10名非糖尿病对照者比较。
- 所有10例患者均在宾夕法尼亚大学医院按CIT07方案接受肝内胰岛移植。
- 采用分步高胰岛素-低血糖钳夹和配对高胰岛素-正常血糖钳夹并输注6,6-2H2-葡萄糖,评估反向调节激素、内生葡萄糖生成和自主神经症状反应。
主要发现
- 所有患者在24个月内维持接近正常血糖(HbA1c≤6.5%;血糖70-180 mg/dL时间≥95%),其中1例恢复低剂量胰岛素治疗。
- 胰岛素诱导低血糖时,胰高血糖素分泌在6个月和18个月时未完全恢复。
- 肾上腺素在6个月时改善,18个月时恢复正常。
- 内生葡萄糖生成和症状在移植前缺失,移植后6个月和18个月时恢复正常。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Islet transplantation has been shown to improve glucose counterregulation and hypoglycemia symptom recognition in patients with type 1 diabetes (T1D) complicated by severe hypoglycemia episodes and symptom unawareness, but long-term data are lacking. OBJECTIVE: To assess the long-term durability of glucose counterregulation and hypoglycemia symptom responses 18 months after intrahepatic islet transplantation and associated measures of glycemic control during a 24-month follow-up period. DESIGN, SETTING, AND PARTICIPANTS: Ten patients with T1D disease duration of approximately 27 years were studied longitudinally before and 6 and 18 months after transplant in the Clinical & Translational Research Center of the University of Pennsylvania and were compared to 10 nondiabetic control subjects. INTERVENTION: All 10 patients underwent intrahepatic islet transplantation according to the CIT07 protocol at the Hospital of the University of Pennsylvania. MAIN OUTCOME MEASURES: Counterregulatory hormone, endogenous glucose production, and autonomic symptom responses derived from stepped hyperinsulinemic-hypoglycemic and paired hyperinsulinemic-euglycemic clamps with infusion of 6,6-2H2-glucose. RESULTS: Near-normal glycemia (HbA1c ≤ 6.5%; time 70-180 mg/dL ≥ 95%) was maintained for 24 months in all patients, with one returning to low-dose insulin therapy. In response to insulin-induced hypoglycemia, glucagon secretion was incompletely restored at 6 and 18 months, epinephrine was improved at 6 months and normalized at 18 months, and endogenous glucose production and symptoms, absent before, were normalized at 6 and 18 months after transplant. CONCLUSIONS: In patients with T1D experiencing problematic hypoglycemia, intrahepatic islet transplantation can lead to long-term improvement of glucose counterregulation and hypoglycemia symptom recognition, physiological effects that likely contribute to glycemic stability after transplant.
引用
- Rickels MR, Peleckis AJ, Markmann E, et al. Long-Term Improvement in Glucose Control and Counterregulation by Islet Transplantation for Type 1 Diabetes. J Clin Endocrinol Metab. 2016. PMID: 27571180
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。